Arcturus Therapeutics Holdings Inc.
- ARCT
- NASDAQ
- Biotechnology
- RNA Therapeutics
- mRNA Vaccines
- Rare Disease Treatments
$10.34
Today −8.25%Quote Oct 16, 2026, 08:00 PM UTC
−38.92%over the last month
Max drawdown −38.9%From 1-month high −38.9%3 months +73.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$293.9M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$30.50
+195.0% from here
Floor
$8.98
13.1% below price
Where the price sits
21 analysts
Analyst range, low to high
$20.00$41.00
- Price $10.34
- Resistance $10.51
- Consensus $30.50
The price is right under resistance. Analysts' average target sits about 195% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ARCTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $3.0M
- Grant$2.1M70.3%
- Collaboration Revenue$880,00029.7%
Industry
Biotechnology
Employees
109
Founded
2013